Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2025-12-24 @ 4:48 PM
NCT ID:
NCT00501150
Eligibility Criteria:
Inclusion Criteria:
1. Prescribed five or more days glycopeptide
2. Fulfil IV-oral switch criteria (see below) with likelihood of discharge within next 48 hours.
Exclusion Criteria:
1. Renal dialysis out patients
2. Suspected or proven left sided endocarditis/osteomyelitis/prosthetic infection where the prosthesis cannot be removed
3. Per-protocol prescribing in haematology (i.e. where teicoplanin is prescribed in response to failure of fever resolution in neutropenic patients without microbiological or clinical evidence of gram positive infection).
4. Age \< 16 years
5. Pregnant or lactating female.
6. Other contraindication to linezolid
7. Clinically unlikely to be discharged within study period or at end of antibiotic therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00501150
Study Brief:
Protocol Section:
NCT00501150